LXEO

Lexeo Therapeutics, Inc. · Healthcare · Market cap $242.9M

Insiders sold $18K net in the last 90 days ·3 sellers, 0 buyers· latest Form 4 filed Nov 18, 2026

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$746K

reported sales (SEC code S)

Unique Insiders

4

in the rolling window

Latest filing

Nov 18, 2026

Tamayo Louis Edward

Lexeo Therapeutics, Inc. (LXEO) has 25 SEC Form 4 filings (29 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Nov 18, 2026.

Inside the rolling window, 4 insiders at Lexeo Therapeutics, Inc. reported no open-market purchases and 16 open-market sales totaling $746K. The most active filer is Chief Operating Officer Otero Jose Manuel with 6 filings. Insiders have net sold $318K over the trailing 6 months. The most recent open-market filing is a sale of 1,007 shares by Chief Financial Officer Tamayo Louis Edward, dated Nov 17, 2026, worth $3K.

  • Industry:Biotechnology
  • CEO:R. Nolan Townsend
  • Employees:63
  • HQ:New York City, NY, US
  • IPO:2023-11-03
Source
Tamayo Louis EdwardFirst in 3 months
Sale$3KNov 18SEC ↗
Otero Jose ManuelFirst in 3 months
Sale$4KNov 18SEC ↗
Townsend Richard NolanFirst in 3 months
Sale$11KNov 18SEC ↗
Sale$17KAug 19SEC ↗
Sale$6KAug 19SEC ↗
Sale$20KAug 19SEC ↗
Sale$21KJul 1SEC ↗
Sale$21KJul 1SEC ↗
Sale$99KJul 1SEC ↗
Sale$116KJul 1SEC ↗
Sale$17KMay 20SEC ↗
Sale$7KMay 20SEC ↗
Sale$313KApr 7SEC ↗
Otero Jose ManuelFirst filing
Sale$7KFeb 20SEC ↗
Otero Jose ManuelFirst filing
Sale$19KFeb 20SEC ↗
Sale$65KFeb 20SEC ↗
Showing 1–16 of 16
1 / 1

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does LXEO have?

Lexeo Therapeutics, Inc. (LXEO) has 25 SEC Form 4 filings (29 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Nov 18, 2026.

When was the most recent SEC Form 4 filing for LXEO?

The most recent Form 4 filing for LXEO on Tracefour is dated Nov 18, 2026.

Who is the most active insider at LXEO?

The most active SEC Form 4 filer at LXEO in the rolling window is Chief Operating Officer Otero Jose Manuel, with 6 filings.

What is the net insider flow at LXEO over the last 6 months?

Over the trailing 180 days, insiders at LXEO have net sold $318K based on SEC Form 4 disclosures.

What is the total insider buy and sell value at LXEO in the current window?

Inside the rolling window, insiders at LXEO bought $0 and sold $746K based on SEC Form 4 filings.

Can I get alerts for LXEO insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Lexeo Therapeutics, Inc. (LXEO). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Lexeo Therapeutics, Inc. is in the Healthcare sector.